Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:administeredBy |
oral
|
| gptkbp:alsoKnownAs |
oseltamivir phosphate
|
| gptkbp:approvalYear |
1999
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AH02
|
| gptkbp:chemicalFormula |
C16H28N2O4
|
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| gptkbp:drugClass |
neuraminidase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
GS-4104
|
| gptkbp:marketedAs |
gptkb:Tamiflu
|
| gptkbp:relatedTo |
gptkb:zanamivir
|
| gptkbp:sideEffect |
nausea
vomiting headache |
| gptkbp:usedFor |
treatment of influenza
|
| gptkbp:bfsParent |
gptkb:132539-06-1
|
| gptkbp:bfsLayer |
7
|